RxSight (RXST) Total Current Liabilities (2020 - 2026)

RxSight (RXST) has reported Total Current Liabilities for 7 consecutive years, with $80.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 294.66% year-over-year to $80.4 million; the trailing twelve-month figure through Jun 2026 stood at $80.4 million (up 294.66% YoY), and the FY2025 full-year result was $26.3 million, up 1.46% from the prior year.
• Total Current Liabilities climbed to $80.4 million in Q2 2026 per RXST's latest filing, from $27.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $80.4 million in Q2 2026 and bottomed at $10.7 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $23.0 million across 5 years, with a median of $20.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities dropped 1.53% in 2025, then soared 294.66% in 2026.
• Over 5 years, Total Current Liabilities stood at $17.2 million in 2022, then increased by 21.27% to $20.9 million in 2023, then gained by 23.79% to $25.9 million in 2024, then advanced by 1.46% to $26.3 million in 2025, then soared by 206.42% to $80.4 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $80.4 million, $27.4 million, and $26.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.